Date Published
Country
Source
Videos
close
-
COVID-19: How the UK's Great Vaccine Gamble Paid Off
After a desperate, deadly year of coronavirus, the UK's vaccination programme has delivered first doses to 15 million of the oldest and most vulnerable. -
UK Only Buying Enough Vaccines to Protect the Most Vulnerable
Every vaccine bought for the UK has been on the assumption that just 30 million people - less than half the population - will get it.Comments
-
Novavax: Late-Stage Trial of Potential COVID-19 Vaccine Begins in UK
Two COVID-19 vaccines being tested in the UK have moved on to the third phase of trials, marking a significant step forward in the development process.Comments
-
Cheap, Widely Used Steroid Dexamethasone Reduces Risk of Death from Covid-19: Study
A low-cost, widely used anti-inflammatory drug improved survival in patients with Covid-19, the first treatment to show life-saving promise months into the pandemic.Comments
-
The Professor Behind the Coronavirus Drug Breakthrough
Professor Peter Horby, Professor of Emerging Infectious Diseases and Global Health, has said that dexamethasone is the 'only drug shown to reduce mortality'.Comments
-
UK Government 'Betting on COVID-19 Vaccines that May Not Work', Scientists Warn
Around 90% of experimental vaccines never reach the clinic because of problems in development or manufacture.Comments
Comments